Search for: "BRISTOL-MYERS SQUIBB" Results 81 - 100 of 870
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jun 2017, 4:57 am by Walter Olson
My new Cato post applauds the Supreme Court for its 8-1 decision yesterday in Bristol-Myers Squibb v. [read post]
12 May 2013, 9:02 pm by Patent Docs
Bristol-Myers Squibb Co. v. [read post]
9 Feb 2019, 9:50 pm by Patent Docs
LexisNexis will be offering a webinar on "The Next Billion-Dollar Acquisition in Pharma -- A Forward-Looking Patent Analysis on Bristol-Myers Squibb Acquiring Celgene" on February 11, 2019 at 2:00 pm (ET). [read post]
11 May 2007, 6:51 am
Further to the Plavix saga involving Bristol Myers Squibb and Apotex, BMS is to plead guilty to a charge of making false statements to a federal agency.The Asbury Park Press reported on May 11:Bristol-Myers Squibb Co., which employs about 7,700 workers in New Jersey, said today [May 11] it agreed to plead guilty to federal charges of making false statements to a government agency and pay a fine of up to $1 million in connection with its failed… [read post]
16 Jul 2010, 12:00 pm by Lucas A. Ferrara, Esq.
Bristol-Myers Squibb is committed to ensuring patient safety and is working to resolve this issue quickly and appropriately. [read post]
9 Apr 2010, 12:15 am by White Collar Crime Prof Blogger
Schiff, the court stated: "Frederick Schiff and Richard Lane were high-ranking corporate executives at the pharmaceutical giant Bristol-Myers Squibb ("Bristol"). [read post]
30 Aug 2015, 9:53 pm by Patent Docs
Bristol-Myers Squibb Co. et al. v. [read post]
3 Sep 2021, 6:36 pm by Lawrence B. Ebert
Patent No. 6,967,208 (“the ’208 patent”): (1) “substituted with [N] R,” see Bristol-Myers Squibb Co. v. [read post]
3 Aug 2012, 7:57 am by By PETER J. HENNING
According to a complaint filed by the Securities and Exchange Commission, an employee of Bristol-Myers Squibb did little to cover his tracks when he engaged in an insider trading scheme that generated over $300,000 in profits. [read post]
15 Feb 2008, 6:19 am
  It is marketed by Bristol Myers Squibb and is a potent antiplatelet agent used for coronary arterial disease and other vascular diseases. [read post]
16 Jan 2012, 7:39 am by Tom Huddleston Jr.
., in its sale to Bristol-Myers Squibb for $2.5 billion--a 163 percent premium over Inhibitex's January 6 closing price. [read post]
3 Aug 2012, 7:57 am by By PETER J. HENNING
According to a complaint filed by the Securities and Exchange Commission, an employee of Bristol-Myers Squibb did little to cover his tracks when he engaged in an insider trading scheme that generated over $300,000 in profits. [read post]
1 Oct 2018, 2:24 am by tortsprof
The drug was brought into the U.S. market by Otsuka America and Bristol-Myers Squibb in 2002.... [read post]